Exploring non-drug treatments for Alzheimer's and related dementias
Research Program on Cognition and Neuromodulation Based Interventions (RP-CNBI)
This study is looking for ways to help older adults with Alzheimer's and similar conditions improve their thinking skills and daily activities without using medication, while also training new researchers to find better treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11076681 on NIH RePORTER |
What this research studies
This research program focuses on developing and implementing non-pharmacologic interventions aimed at improving cognition and daily functioning in older adults with Alzheimer's disease and related dementias. It aims to create a strong infrastructure that includes access to well-characterized participants, advanced neuroimaging tools, and telehealth platforms for treatment delivery. The program also emphasizes training the next generation of researchers in innovative treatment approaches and establishing centralized resources for data analysis and treatment evaluation.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with early-stage cognitive impairment or those without a diagnosis of Alzheimer's disease or related dementias may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective non-drug therapies that enhance cognitive function and quality of life for patients with Alzheimer's and related dementias.
How similar studies have performed: Previous research has shown promise in using non-pharmacologic interventions to improve cognitive outcomes in dementia patients, indicating a potential for success in this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Hampstead, Benjamin Michael — University of Michigan at Ann Arbor
- Study coordinator: Hampstead, Benjamin Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.